Catalyst Wire Dossier Catalyst Wire Dossier

PEG-rhGH

pegylated recombinant human growth hormone
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PEG-rhGH, covering 2017-04-07 to 2025-03-07. Get the full timeline:

Most recent: Clinical Trial Update: PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults [Phase 4]

See pricing